trending Market Intelligence /marketintelligence/en/news-insights/trending/jsnjh56_n5d-1idwwoom0q2 content esgSubNav
In This List

Motif Bio board member resigns

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Motif Bio board member resigns

New York-based Motif Bio PLC said Robert Bertoldi will step down from its board, effective July 16.

Motif Bio is a clinical stage biopharmaceutical company that develops and sells pharmaceutical formulations in the U.S.